Vaidya Sane Ayurved Laboratories Past Earnings Performance
Past criteria checks 1/6
Vaidya Sane Ayurved Laboratories has been growing earnings at an average annual rate of 27.4%, while the Healthcare industry saw earnings growing at 30% annually. Revenues have been growing at an average rate of 11% per year. Vaidya Sane Ayurved Laboratories's return on equity is 3.6%, and it has net margins of 2%.
Key information
27.4%
Earnings growth rate
26.3%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 11.0% |
| Return on equity | 3.6% |
| Net Margin | 2.0% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How Vaidya Sane Ayurved Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 993 | 20 | 269 | 0 |
| 31 Dec 23 | 1,020 | 26 | 360 | 0 |
| 30 Sep 23 | 1,047 | 33 | 450 | 0 |
| 30 Jun 23 | 1,019 | 41 | 437 | 0 |
| 31 Mar 23 | 992 | 48 | 423 | 0 |
| 31 Dec 22 | 940 | 48 | 336 | 0 |
| 30 Sep 22 | 887 | 48 | 248 | 0 |
| 30 Jun 22 | 817 | 42 | 258 | 0 |
| 31 Mar 22 | 747 | 35 | 268 | 0 |
| 31 Mar 21 | 523 | 4 | 166 | 0 |
| 31 Mar 20 | 752 | -6 | 371 | 0 |
| 31 Mar 19 | 625 | 5 | 307 | 0 |
| 31 Mar 18 | 376 | 11 | 166 | 0 |
Quality Earnings: MADHAVBAUG has a high level of non-cash earnings.
Growing Profit Margin: MADHAVBAUG's current net profit margins (2%) are lower than last year (4.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MADHAVBAUG's earnings have grown significantly by 27.4% per year over the past 5 years.
Accelerating Growth: MADHAVBAUG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MADHAVBAUG had negative earnings growth (-59%) over the past year, making it difficult to compare to the Healthcare industry average (25%).
Return on Equity
High ROE: MADHAVBAUG's Return on Equity (3.6%) is considered low.